Home LiteratureArticle Details
PMID: 12589164 Published · ppublish English Journal Article

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.

Transplantation ·Vol. 75 ·No. 3 ·2003-02-15 ·Pages 389-97

Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC

Abstract

Marrow stromal cells (MSC) can differentiate into multiple mesenchymal tissues. To assess the feasibility of human MSC transplantation, we evaluated the in vitro immunogenicity of MSC and their ability to function as alloantigen presenting cells (APC). Human MSC were derived and used in mixed cell cultures with allogeneic peripheral blood mononuclear cells (PBMC). Expression of immunoregulatory molecules on MSC was analyzed by flow cytometry. An MSC-associated suppressive activity was analyzed using cell-proliferation assays and enzyme-linked immunoassays. MSC failed to elicit a proliferative response when cocultured with allogeneic PBMC, despite provision of a costimulatory signal delivered by an anti-CD28 antibody and pretreatment of MSC with gamma-interferon. MSC express major histocompatibility complex (MHC) class I and lymphocyte function-associated antigen (LFA)-3 antigens constitutively and MHC class II and intercellular adhesion molecule (ICAM)-1 antigens upon gamma-interferon treatment but do not express CD80, CD86, or CD40 costimulatory molecules. MSC actively suppressed proliferation of responder PBMC stimulated by third-party allogeneic PBMC as well as T cells stimulated by anti-CD3 and anti-CD28 antibodies. Separation of MSC and PBMC by a semipermeable membrane did not abrogate the suppression. The suppressive activity could not be accounted for by MSC production of interleukin-10, transforming growth factor-beta1, or prostaglandin E2, nor by tryptophan depletion of the culture medium. Human MSC fail to stimulate allogeneic PBMC or T-cell proliferation in mixed cell cultures. Unlike other nonprofessional APC, this failure of function is not reversed by provision of CD28-mediated costimulation nor gamma-interferon pretreatment. Rather, MSC actively inhibit T-cell proliferation, suggesting that allogeneic MSC transplantation might be accomplished without the need for significant host immunosuppression.

MeSH Terms
Apoptosis/immunology Bone Marrow Cells/cytology Bone Marrow Transplantation CD28 Antigens/immunology Cell Communication/immunology Cell Division/immunology Cells, Cultured Coculture Techniques Dinoprostone/immunology Humans Immunosuppression Therapy Interleukin-10/immunology Lymphocyte Activation/immunology Stromal Cells/cytology,transplantation T-Lymphocytes/cytology,immunology Transforming Growth Factor beta/immunology Transforming Growth Factor beta1
Chemicals
CD28 Antigens TGFB1 protein, human Transforming Growth Factor beta Transforming Growth Factor beta1 Interleukin-10 Dinoprostone
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tse William T
Division of Hematology/Oncology, Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. william.tse@tch.harvard.edu.
Pendleton John D
Beyer Wendy M
Egalka Matthew C
Guinan Eva C
Article Info
Journal
Transplantation
Abbr.
Transplantation
ISSN
0041-1337
Published
2003-02-15
Pages
389-97
Language
English
Region
United States
NLM ID
0132144
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com